SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (31535)3/29/2005 2:16:51 PM
From: fred hayes  Read Replies (1) of 32384
 
Nigel, royalty pharma numbers: I make it 3.0125 percent, which is the 1.3875 percent from the 2003 10k plus the 1.625 percent amendment cited in the 9.30.04 10Q. Looks like it applies to all 3 SERM products. I'm looking for Ligand's royalties for these products, anyone have them handy? Casual search has come up empty. If Lasofoxifene is only 3 percent, it looks like Ligand makes nothing here. Could that be right? What about the other 2 SERMs?

fred
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext